Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic
Deprescribing aims to reduce polypharmacy, especially in the elderly population, in order to maintain or improve quality of life, reduce harm from medications, and limit healthcare expenditure. Coronavirus disease (COVID-19) is an infectious disease that has led to a pandemic and has changed the liv...
Saved in:
Published in | Research in social and administrative pharmacy Vol. 17; no. 1; pp. 1942 - 1945 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.01.2021
Published by Elsevier Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Deprescribing aims to reduce polypharmacy, especially in the elderly population, in order to maintain or improve quality of life, reduce harm from medications, and limit healthcare expenditure. Coronavirus disease (COVID-19) is an infectious disease that has led to a pandemic and has changed the lives many throughout the world. The mode of transmission of this virus is from person to person through the transfer of respiratory droplets. Therefore, non-essential healthcare services involving direct patient interactions, including deprescribing, has been on hiatus to reduce spread. Barriers to deprescribing before the pandemic include patient and system related factors, such as resistance to change, patient's knowledge deficit about deprescribing, lack of alternatives for treatment of disease, uncoordinated delivery of health services, prescriber's attitudes and/or experience, limited availability of guidelines for deprescribing, and lack of evidence on preventative therapy. Some of these barriers can be mitigated by using the following interventions:patient education, prioritization of non-pharmacological therapy, incorporation of electronic health record (EHR), continuous prescriber education, and development of research studies on deprescribing. Currently, deprescribing cannot be delivered through in person interactions, so virtual care is a reasonable alternative format. The full incorporation of EHR throughout Canada can add to the success of this strategy. However, there are several challenges of conducting deprescribing virtually in the elderly population. These challenges include, but are not limited, to their inability to use technology, lack of literacy, lack of assistance from others, greater propensity for withdrawal effects, and increased risk of severe consequences, if hospitalized. Virtual care is the future of healthcare and in order to retain the benefits of deprescribing, additional initiatives should be in place to address the challenges that elderly patients may experience in accessing deprescribing virtually. These initiatives should involve teaching elderly patients how to use technology to access health services and with technical support in place to address any concerns. |
---|---|
AbstractList | Deprescribing aims to reduce polypharmacy, especially in the elderly population, in order to maintain or improve quality of life, reduce harm from medications, and limit healthcare expenditure. Coronavirus disease (COVID-19) is an infectious disease that has led to a pandemic and has changed the lives many throughout the world. The mode of transmission of this virus is from person to person through the transfer of respiratory droplets. Therefore, non-essential healthcare services involving direct patient interactions, including deprescribing, has been on hiatus to reduce spread. Barriers to deprescribing before the pandemic include patient and system related factors, such as resistance to change, patient's knowledge deficit about deprescribing, lack of alternatives for treatment of disease, uncoordinated delivery of health services, prescriber's attitudes and/or experience, limited availability of guidelines for deprescribing, and lack of evidence on preventative therapy. Some of these barriers can be mitigated by using the following interventions:patient education, prioritization of non-pharmacological therapy, incorporation of electronic health record (EHR), continuous prescriber education, and development of research studies on deprescribing. Currently, deprescribing cannot be delivered through in person interactions, so virtual care is a reasonable alternative format. The full incorporation of EHR throughout Canada can add to the success of this strategy. However, there are several challenges of conducting deprescribing virtually in the elderly population. These challenges include, but are not limited, to their inability to use technology, lack of literacy, lack of assistance from others, greater propensity for withdrawal effects, and increased risk of severe consequences, if hospitalized. Virtual care is the future of healthcare and in order to retain the benefits of deprescribing, additional initiatives should be in place to address the challenges that elderly patients may experience in accessing deprescribing virtually. These initiatives should involve teaching elderly patients how to use technology to access health services and with technical support in place to address any concerns. |
Author | Tran, Cindy Prabaharan, Thulasika Almasalkhi, Sarah Zhou, Yueyang Elbeddini, Ali |
Author_xml | – sequence: 1 givenname: Ali surname: Elbeddini fullname: Elbeddini, Ali email: aelbeddini@wdmh.on.ca organization: Winchester District Memorial Hospital, 566 Louise Street, Winchester, ON, KK0C2K0, Canada – sequence: 2 givenname: Thulasika surname: Prabaharan fullname: Prabaharan, Thulasika email: thulasika.prabaharan@mail.utoronto.ca organization: Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, M5S 3M2, Canada – sequence: 3 givenname: Sarah surname: Almasalkhi fullname: Almasalkhi, Sarah email: sarah.almasalkhi@mail.utoronto.ca organization: Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, M5S 3M2, Canada – sequence: 4 givenname: Cindy surname: Tran fullname: Tran, Cindy email: cindy.tran@mail.utoronto.ca organization: Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, M5S 3M2, Canada – sequence: 5 givenname: Yueyang surname: Zhou fullname: Zhou, Yueyang email: Yzhou@uottawa.ca organization: Faculty of Science, University of Ottawa, 75 Laurier Ave. East, Ottawa, ON, K1N 6N5, Canada |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32499161$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkN1KxDAQhYMo_j-C0hdozSRNu71RdP2Fhb1RwauQJlM3S5uUpCv49nZdFb3yamaYOecw3wHZdt4hISdAM6BQnC2zqPqFCl3GKKMZFRllYovsQ8XzdAKCbo-9EJCWOcAeOYhxSSkvKeS7ZI-zvKqggH3ycqVCsBhiMvhEe2dWerDuNTHYB4w62Ho9WZcMC0ywNRja96T3_apVg_UuUZ01n7vp_PnhOoUq6ZUz2Fl9RHYa1UY8_qqH5On25nF6n87mdw_Ty1mq86Ic0hrKquDAtW4KXjWUa5gUiCwXrMaK5ZpzoZAygxpoMeGqVkznAkrD64phww_J-ca3X9UdGo1uCKqVfbCdCu_SKyv_bpxdyFf_JksmCsFgNBAbAx18jAGbHy1QuWYtl_KLtVyzllTIkfWoO_0d_KP6hjseXGwOcHz_bYQso7boNBobUA_SePtPxAc-3ZZD |
CitedBy_id | crossref_primary_10_1111_bcpt_13886 crossref_primary_10_1177_17151635221114114 crossref_primary_10_2196_52031 crossref_primary_10_1016_j_bbih_2021_100353 crossref_primary_10_1186_s12911_023_02194_4 crossref_primary_10_1111_jgs_18047 crossref_primary_10_7748_nop_2023_e1449 crossref_primary_10_1089_cyber_2023_0571 crossref_primary_10_3390_ijerph18041755 crossref_primary_10_1016_j_heliyon_2024_e25197 crossref_primary_10_3390_ph15080977 crossref_primary_10_7748_nop_2023_e1441 crossref_primary_10_1016_j_ifacol_2021_10_529 crossref_primary_10_1007_s40266_023_01016_6 crossref_primary_10_53886_gga_e0210059 crossref_primary_10_1007_s40266_024_01110_3 crossref_primary_10_1177_14604582221075561 |
Cites_doi | 10.1016/j.jaut.2020.102433 10.1016/j.sapharm.2019.07.004 10.1016/j.sapharm.2015.12.004 10.7812/TPP/17-157 10.1186/s12875-019-0953-4 10.1002/hsr2.45 10.1016/j.jamda.2019.08.031 10.1016/j.sapharm.2018.08.012 10.1111/jcpt.12688 10.1016/j.sapharm.2020.03.003 10.1016/j.sapharm.2018.08.014 10.1016/j.sapharm.2017.01.003 10.1016/j.sapharm.2016.08.006 10.1016/j.maturitas.2020.01.009 10.3906/sag-2004-172 10.1016/j.sapharm.2020.04.029 |
ContentType | Journal Article |
Copyright | 2020 Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved. Crown Copyright © 2020 Published by Elsevier Inc. All rights reserved. 2020 |
Copyright_xml | – notice: 2020 – notice: Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved. – notice: Crown Copyright © 2020 Published by Elsevier Inc. All rights reserved. 2020 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1016/j.sapharm.2020.05.025 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1934-8150 |
EndPage | 1945 |
ExternalDocumentID | 10_1016_j_sapharm_2020_05_025 32499161 S1551741120306021 |
Genre | Journal Article |
GeographicLocations | Canada |
GeographicLocations_xml | – name: Canada |
GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1CY 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAWTL AAXUO ABIVO ABLVK ABMAC ABMZM ABXDB ABYKQ ABZDS ACDAQ ACGFS ACHQT ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV C45 CS3 DU5 EBS EFJIC EFLBG EJD EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM LCYCR M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SEL SES SPCBC SSH SSP SSZ T5K TEORI ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX ACRPL ADNMO CITATION 5PM |
ID | FETCH-LOGICAL-c467t-b1796313ccf639f03c186ee2452be924c335ae02dec10683aba2c4517d3b92ef3 |
IEDL.DBID | .~1 |
ISSN | 1551-7411 |
IngestDate | Tue Sep 17 21:06:33 EDT 2024 Fri Dec 06 03:38:52 EST 2024 Sat Nov 02 12:01:02 EDT 2024 Fri Feb 23 02:47:06 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | COVID-19 Virtual care Elderly population Deprescribing Drug safety |
Language | English |
License | Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c467t-b1796313ccf639f03c186ee2452be924c335ae02dec10683aba2c4517d3b92ef3 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7256521 |
PMID | 32499161 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7256521 crossref_primary_10_1016_j_sapharm_2020_05_025 pubmed_primary_32499161 elsevier_sciencedirect_doi_10_1016_j_sapharm_2020_05_025 |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Research in social and administrative pharmacy |
PublicationTitleAlternate | Res Social Adm Pharm |
PublicationYear | 2021 |
Publisher | Elsevier Inc Published by Elsevier Inc |
Publisher_xml | – name: Elsevier Inc – name: Published by Elsevier Inc |
References | Bulut, Kato (bib7) 2020; 50 (bib19) 2020 Trenaman, Willison, Robinson, Andrew (bib16) 2019; 16 Szperling (bib26) 2020 (bib25) 2018 Abu Fadaleh, Shkrobot, Makhinova, Eurich, Sadowski (bib4) 2020 bib10 Kalogianis, Wimmer, Turner (bib15) 2016; 12 Gillespie, Harrison, Mullan (bib13) 2018; 1 Sirois, Ouellet, Reeve (bib14) 2017; 13 (bib24) 2020 Farrell, Richardson, Raman-Wilms, de Launay, Alsabbagh, Conklin (bib23) 2018; 14 D'Avanzo, Agosti, Reeve (bib17) 2020; 134 Djatche, Lee, Singer, Hegarty, Lombardi, Maio (bib18) 2018; 43 Kuntz (bib11) 2018; 22 Zechmann, Trueb, Valeri, Streit, Senn, Neuner-Jehle (bib12) 2019; 20 Dharmarajan, Choi, Hossain (bib9) 2020 Page, Potter, Clifford, Etherton-Beer (bib3) 2016 Rothan, Byrareddy (bib6) 2020; 109 Conklin, Farrell, Suleman (bib20) 2019; 15 (bib2) 2020 bib5 (bib8) 2016 Moriarity, Pottie, Dolovih, McCarthy (bib21) 2019; 15 bib1 Bredhold, Deodhar, Davis, DiRenzo, Isaacs, Campbell (bib22) 2020 33288419 - Res Social Adm Pharm. 2021 May;17(5):1024-1025 Conklin (10.1016/j.sapharm.2020.05.025_bib20) 2019; 15 Sirois (10.1016/j.sapharm.2020.05.025_bib14) 2017; 13 Bulut (10.1016/j.sapharm.2020.05.025_bib7) 2020; 50 D'Avanzo (10.1016/j.sapharm.2020.05.025_bib17) 2020; 134 Moriarity (10.1016/j.sapharm.2020.05.025_bib21) 2019; 15 Page (10.1016/j.sapharm.2020.05.025_bib3) 2016 Rothan (10.1016/j.sapharm.2020.05.025_bib6) 2020; 109 (10.1016/j.sapharm.2020.05.025_bib8) 2016 Abu Fadaleh (10.1016/j.sapharm.2020.05.025_bib4) 2020 Kuntz (10.1016/j.sapharm.2020.05.025_bib11) 2018; 22 Djatche (10.1016/j.sapharm.2020.05.025_bib18) 2018; 43 Kalogianis (10.1016/j.sapharm.2020.05.025_bib15) 2016; 12 Dharmarajan (10.1016/j.sapharm.2020.05.025_bib9) 2020 (10.1016/j.sapharm.2020.05.025_bib19) 2020 Farrell (10.1016/j.sapharm.2020.05.025_bib23) 2018; 14 Zechmann (10.1016/j.sapharm.2020.05.025_bib12) 2019; 20 Bredhold (10.1016/j.sapharm.2020.05.025_bib22) 2020 Szperling (10.1016/j.sapharm.2020.05.025_bib26) Gillespie (10.1016/j.sapharm.2020.05.025_bib13) 2018; 1 Trenaman (10.1016/j.sapharm.2020.05.025_bib16) 2019; 16 |
References_xml | – ident: bib10 article-title: Deprescribing initiatives in Canada – volume: 12 start-page: 784 year: 2016 end-page: 788 ident: bib15 article-title: Are residents of aged care facilities willing to have their medications deprescribed? publication-title: Res Soc Adm Pharm contributor: fullname: Turner – volume: 134 start-page: 29 year: 2020 end-page: 33 ident: bib17 article-title: Views of medical practitioners about deprescribing in older adults: findings from an Italian qualitative study publication-title: Maturitas contributor: fullname: Reeve – volume: 22 start-page: 17 year: 2018 end-page: 157 ident: bib11 article-title: Barriers and facilitators to the deprescribing of nonbenzodiazepine sedative medications among older adults publication-title: Perm J contributor: fullname: Kuntz – volume: 20 start-page: 64 year: 2019 ident: bib12 article-title: Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland publication-title: BMC Fam Pract contributor: fullname: Neuner-Jehle – volume: 109 year: 2020 ident: bib6 article-title: The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak publication-title: J Autoimmun contributor: fullname: Byrareddy – year: 2016 ident: bib3 article-title: Deprescribing in Older People contributor: fullname: Etherton-Beer – volume: 13 start-page: 864 year: 2017 end-page: 870 ident: bib14 article-title: Community-dwelling older people's attitudes towards deprescribing in Canada publication-title: Res Soc Adm Pharm contributor: fullname: Reeve – year: 2016 ident: bib8 publication-title: Drug Use Among Seniors in Canada – volume: 16 start-page: 595 year: 2019 end-page: 598 ident: bib16 article-title: A collaborative intervention for deprescribing: the role of stakeholder and patient engagement publication-title: Res Soc Adm Pharm contributor: fullname: Andrew – volume: 43 start-page: 550 year: 2018 end-page: 555 ident: bib18 article-title: How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing? publication-title: J Clin Pharm Therapeut contributor: fullname: Maio – year: 2020 ident: bib26 article-title: Ottawa non-profit organization helps seniors connect during COVID pandemic contributor: fullname: Szperling – volume: 15 year: 2019 ident: bib20 article-title: Implementing deprescribing guidelines into frontline practice: barriers and facilitators publication-title: Res Soc Adm Pharm contributor: fullname: Suleman – volume: 14 start-page: 18 year: 2018 end-page: 25 ident: bib23 article-title: Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines publication-title: Res Soc Adm Pharm contributor: fullname: Conklin – year: 2020 ident: bib2 article-title: What is deprescribing? — do I still need this medication? Is deprescribing for you? – start-page: 355 year: 2020 end-page: 360 ident: bib9 article-title: Deprescribing as a clinical improvement focus publication-title: J Am Med Dir Assoc contributor: fullname: Hossain – year: 2020 ident: bib19 publication-title: Progress in Canada – year: 2020 ident: bib24 article-title: Rapid response to COVID-19 – volume: 50 start-page: 563 year: 2020 end-page: 566 ident: bib7 article-title: Epidemiology of COVID-19 publication-title: Turk J Med Sci contributor: fullname: Kato – year: 2018 ident: bib25 article-title: Living arrangements of seniors – year: 2020 ident: bib22 article-title: Deprescribing opportunities for elderly inpatients in an academic, safety-net health system publication-title: Res Soc Adm Pharm contributor: fullname: Campbell – volume: 15 start-page: 806 year: 2019 end-page: 810 ident: bib21 article-title: Deprescribing recommendations: an essential consideration for clinical guidelines developers publication-title: Res Soc Adm Pharm contributor: fullname: McCarthy – ident: bib5 article-title: Q&A on coronaviruses (COVID-19) – year: 2020 ident: bib4 article-title: Financial advantage or barrier when deprescribing for seniors: a case based analysis publication-title: Res Soc Adm Pharm contributor: fullname: Sadowski – ident: bib1 article-title: Deprescribing: managing medications to reduce polypharmacy – volume: 1 start-page: e45 year: 2018 ident: bib13 article-title: Deprescribing medications for older adults in the primary care context: a mixed studies review publication-title: Health Sci Rep contributor: fullname: Mullan – volume: 109 year: 2020 ident: 10.1016/j.sapharm.2020.05.025_bib6 article-title: The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak publication-title: J Autoimmun doi: 10.1016/j.jaut.2020.102433 contributor: fullname: Rothan – year: 2020 ident: 10.1016/j.sapharm.2020.05.025_bib19 – ident: 10.1016/j.sapharm.2020.05.025_bib26 contributor: fullname: Szperling – volume: 16 start-page: 595 issue: 4 year: 2019 ident: 10.1016/j.sapharm.2020.05.025_bib16 article-title: A collaborative intervention for deprescribing: the role of stakeholder and patient engagement publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2019.07.004 contributor: fullname: Trenaman – volume: 12 start-page: 784 issue: 5 year: 2016 ident: 10.1016/j.sapharm.2020.05.025_bib15 article-title: Are residents of aged care facilities willing to have their medications deprescribed? publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2015.12.004 contributor: fullname: Kalogianis – volume: 22 start-page: 17 year: 2018 ident: 10.1016/j.sapharm.2020.05.025_bib11 article-title: Barriers and facilitators to the deprescribing of nonbenzodiazepine sedative medications among older adults publication-title: Perm J doi: 10.7812/TPP/17-157 contributor: fullname: Kuntz – volume: 20 start-page: 64 issue: 1 year: 2019 ident: 10.1016/j.sapharm.2020.05.025_bib12 article-title: Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland publication-title: BMC Fam Pract doi: 10.1186/s12875-019-0953-4 contributor: fullname: Zechmann – year: 2016 ident: 10.1016/j.sapharm.2020.05.025_bib3 contributor: fullname: Page – volume: 1 start-page: e45 issue: 7 year: 2018 ident: 10.1016/j.sapharm.2020.05.025_bib13 article-title: Deprescribing medications for older adults in the primary care context: a mixed studies review publication-title: Health Sci Rep doi: 10.1002/hsr2.45 contributor: fullname: Gillespie – start-page: 355 year: 2020 ident: 10.1016/j.sapharm.2020.05.025_bib9 article-title: Deprescribing as a clinical improvement focus publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2019.08.031 contributor: fullname: Dharmarajan – volume: 15 issue: 6 year: 2019 ident: 10.1016/j.sapharm.2020.05.025_bib20 article-title: Implementing deprescribing guidelines into frontline practice: barriers and facilitators publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2018.08.012 contributor: fullname: Conklin – volume: 43 start-page: 550 issue: 4 year: 2018 ident: 10.1016/j.sapharm.2020.05.025_bib18 article-title: How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing? publication-title: J Clin Pharm Therapeut doi: 10.1111/jcpt.12688 contributor: fullname: Djatche – year: 2020 ident: 10.1016/j.sapharm.2020.05.025_bib4 article-title: Financial advantage or barrier when deprescribing for seniors: a case based analysis publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2020.03.003 contributor: fullname: Abu Fadaleh – volume: 15 start-page: 806 issue: 6 year: 2019 ident: 10.1016/j.sapharm.2020.05.025_bib21 article-title: Deprescribing recommendations: an essential consideration for clinical guidelines developers publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2018.08.014 contributor: fullname: Moriarity – year: 2016 ident: 10.1016/j.sapharm.2020.05.025_bib8 – volume: 14 start-page: 18 issue: 1 year: 2018 ident: 10.1016/j.sapharm.2020.05.025_bib23 article-title: Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2017.01.003 contributor: fullname: Farrell – volume: 13 start-page: 864 issue: 4 year: 2017 ident: 10.1016/j.sapharm.2020.05.025_bib14 article-title: Community-dwelling older people's attitudes towards deprescribing in Canada publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2016.08.006 contributor: fullname: Sirois – volume: 134 start-page: 29 year: 2020 ident: 10.1016/j.sapharm.2020.05.025_bib17 article-title: Views of medical practitioners about deprescribing in older adults: findings from an Italian qualitative study publication-title: Maturitas doi: 10.1016/j.maturitas.2020.01.009 contributor: fullname: D'Avanzo – volume: 50 start-page: 563 issue: 3 year: 2020 ident: 10.1016/j.sapharm.2020.05.025_bib7 article-title: Epidemiology of COVID-19 publication-title: Turk J Med Sci doi: 10.3906/sag-2004-172 contributor: fullname: Bulut – year: 2020 ident: 10.1016/j.sapharm.2020.05.025_bib22 article-title: Deprescribing opportunities for elderly inpatients in an academic, safety-net health system publication-title: Res Soc Adm Pharm doi: 10.1016/j.sapharm.2020.04.029 contributor: fullname: Bredhold |
SSID | ssj0037014 |
Score | 2.3724768 |
Snippet | Deprescribing aims to reduce polypharmacy, especially in the elderly population, in order to maintain or improve quality of life, reduce harm from medications,... |
SourceID | pubmedcentral crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1942 |
SubjectTerms | Aged Canada Computer Literacy COVID-19 COVID-19 - prevention & control COVID-19 - transmission Delivery of Health Care - economics Delivery of Health Care - organization & administration Deprescribing Deprescriptions Drug safety Drug-Related Side Effects and Adverse Reactions - prevention & control Elderly population Electronic Health Records Health Care Costs Health Services Accessibility Humans Polypharmacy Quality of Life Telemedicine Virtual care |
Title | Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic |
URI | https://dx.doi.org/10.1016/j.sapharm.2020.05.025 https://www.ncbi.nlm.nih.gov/pubmed/32499161 https://pubmed.ncbi.nlm.nih.gov/PMC7256521 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELaqsrAg3pRH5QExkTaJnUfHUqjKQ1BBQTBFtuOIVBCitgxd-O3cOWlLp0pMUWJHse6cu-_s83eEnDIheMJ4y1KAPXCbkVtSisDytasTHrrSVybb4t7vPfObV--1QjqzszCYVlna_sKmG2tdPmmW0mzmadp8QmcP_tBxEfba5jA592ysYtD4mad5sMA2_N7Y2cLei1M8zWFjLHIkiIYw0bUNgSdWzF7hn5ZzJ_84o-4m2ShRJG0XA90iFZ1tk7N-QUM9PaeDxamq8Tk9o_0FQfV0h7xdiBEWqhvTyReFeBgpX8GD0SIrFsyIxLs0owAOqcYy3h9Tms8rfVHxmcamrfPwcn1pOS2a41L0Z6p2yXP3atDpWWWJBUuBhZxYEv5HnzlMqQSgSmIz5YS-1rgdKzWEZooxT2jbjbWC2DFkQgpXcZB7zGQLtMn2SDX7yvQBoSEXfgxg0fV1wG2uAQh7IolbIXNi5FmrkcZMsFFeMGlEsxSzYVRqIkJNRLYXgSZqJJyJP1qaEhFY-1Wv7hdamn8JcCMiYadGgiX9zTsgzfZyS5a-G7rtAFAhgJzD_w_niKy7mApjVm6OSXUy-tYngGUmsm4ma52stTuPd328Xt_27n8BIfn2zA |
link.rule.ids | 230,314,780,784,885,4502,24116,27924,27925,45585,45679 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELYQDLAg3pSnB9SpaZPYeXSEAipQoBIFwWTZjiNSQYjaMnTht3OXpC2dKjEmdpTozrn7zr77jpAzJiWPGW9aGrAHHjNySykZWL5xTcxDV_k6z7Z48NvP_PbVe10irUktDKZVlra_sOm5tS7vNEppNrIkaTyhswd_6LgIe20sJl_hHqBfWNT1n2meBwvsnOAbZ1s4fVbG0-jXhzJDhmiIE107Z_DEltkLHNR88uQfb3S9QdZLGEnPiy_dJEsm3SLVbsFDPa7R3qysalijVdqdMVSPt8nbhRxgp7ohHX1RCIiR8xVcGC3SYsGOKLxKUgrokBrs4_0xptm01ReVn0mUj7UeX24uLadJM9yL_kz0Dnm-vuq12lbZY8HSYCJHloIf0mcO0zoGrBLbTDuhbwyexyoDsZlmzJPGdiOjIXgMmVTS1RwEHzHVBHWyXbKcfqVmn9CQSz8CtOj6JuA2N4CEPRlHzZA5ERKtVUh9IliRFVQaYpJj1helJgRqQtieAE1USDgRv5hbEwLM_aJH9wotTd8EwBGhsFMhwZz-phOQZ3t-JE3ec77tAGAhoJyD_3_OKVlt9-47onPzcHdI1lzMi8m3cY7I8mjwbY4B2IzUSb5wfwEz9_bU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Barriers+to+conducting+deprescribing+in+the+elderly+population+amid+the+COVID-19+pandemic&rft.jtitle=Research+in+social+and+administrative+pharmacy&rft.au=Elbeddini%2C+Ali&rft.au=Prabaharan%2C+Thulasika&rft.au=Almasalkhi%2C+Sarah&rft.au=Tran%2C+Cindy&rft.date=2021-01-01&rft.issn=1551-7411&rft.volume=17&rft.issue=1&rft.spage=1942&rft.epage=1945&rft_id=info:doi/10.1016%2Fj.sapharm.2020.05.025&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_sapharm_2020_05_025 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1551-7411&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1551-7411&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1551-7411&client=summon |